One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
We hypothesized that chronic oral administration of the phosphodiesterase-5 inhibitor sildenafil could improve the exercise capacity and pulmonary hemodynamics in patients with pulmonary arterial hypertension (PAH) on the basis of previous short-term studies. We tested this hypothesis in 14 subjects...
Main Authors: | A.C. Barreto, S.M. Franchi, C.R.P. Castro, A.A. Lopes |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2005-02-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000200006 |
Similar Items
-
DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE
by: E. A. Zhuk, et al.
Published: (2012-06-01) -
Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
by: Sarah Beshay, et al.
Published: (2022-01-01) -
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
by: Anne M Keogh, et al.
Published: (2008-10-01) -
Pulmonary veno‐occlusive disease with vanished pulmonary consolidation
by: Kei Yamasaki, et al.
Published: (2023-10-01) -
Sildenafil in Infants and Children
by: Larisa Simonca, et al.
Published: (2017-07-01)